Insider · CIK 0001326530

Blanchard Cheryl R

Reports to the SEC for 7 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001326530

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-04-15	XLOXilio Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2026-03-15	ANIKAnika Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−12.1K sh	$14.20	−$172K	258,788
2026-03-15	ANIKAnika Therapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−25.1K sh	—	—	25,132
2026-03-15	ANIKAnika Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+25.1K sh	—	—	270,892
2026-03-14	ANIKAnika Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+24.5K sh	—	—	235,969
2026-03-14	ANIKAnika Therapeutics, Inc.A Award	Director	AAward	+24.5K sh	—	—	260,489
2026-03-14	ANIKAnika Therapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−24.5K sh	—	—	49,040
2026-03-14	ANIKAnika Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−14.7K sh	$14.20	−$209K	245,761
2026-03-09	ANIKAnika Therapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2026-03-09	ANIKAnika Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	—	—	217,321
2026-03-09	ANIKAnika Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−5,871 sh	$14.96	−$87.8K	211,450
2025-08-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−36.7K sh	—	—	0
2025-08-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.9K sh	—	—	0
2025-08-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−24.8K sh	—	—	0
2025-08-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2025-08-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,432 sh	—	—	0
2025-08-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.2K sh	—	—	0
2025-08-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−18.1K sh	—	—	0
2025-08-05	Vigil Neuroscience, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2025-08-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,017 sh	—	—	0
2025-05-22	Vigil Neuroscience, Inc.A Award	Director	AAward	+5,000 sh	—	—	5,000
2025-03-17	ANIKAnika Therapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−25.1K sh	—	—	50,263
2025-03-17	ANIKAnika Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−12.2K sh	$15.91	−$193K	197,320
2025-03-17	ANIKAnika Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+25.1K sh	—	—	209,472
2025-03-14	ANIKAnika Therapeutics, Inc. · Restricted Stock UnitA Award	Director	AAward	+73.6K sh	—	—	73,559
2025-03-14	ANIKAnika Therapeutics, Inc. · Restricted Stock UnitA Award	Director	AAward	+71.4K sh	—	—	71,403
2025-03-11	ANIKAnika Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+30.1K sh	—	—	197,015
2025-03-11	ANIKAnika Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−12.7K sh	$16.79	−$213K	184,340
2025-03-11	ANIKAnika Therapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−30.1K sh	—	—	0
2025-03-10	ANIKAnika Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−5,871 sh	$16.62	−$97.6K	166,955
2025-03-10	ANIKAnika Therapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	20,001
2025-03-10	ANIKAnika Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	—	—	172,826
2024-06-05	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)A Award	Director	AAward	+18.1K sh	—	—	18,068
2024-05-03	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)A Award	Director	AAward	+13.9K sh	—	—	13,928
2024-05-03	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.9K sh	—	—	0
2024-05-03	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)A Award	Director	AAward	+6,432 sh	—	—	6,432
2024-05-03	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,432 sh	$7.62	−$49K	0
2024-05-03	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)A Award	Director	AAward	+12.2K sh	—	—	12,155
2024-05-03	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.2K sh	—	—	0
2024-05-03	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)A Award	Director	AAward	+5,017 sh	—	—	5,017
2024-05-03	Vigil Neuroscience, Inc.Stock Option Award (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,017 sh	$9.63	−$48.3K	0
2024-03-15	ANIKAnika Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+183K sh	—	—	182,699
2024-03-15	ANIKAnika Therapeutics, Inc. · Restricted Stock UnitA Award	Director	AAward	+75.4K sh	—	—	75,395
2024-03-11	ANIKAnika Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−14.5K sh	$25.79	−$375K	151,694
2024-03-11	ANIKAnika Therapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−14.4K sh	—	—	0
2024-03-11	ANIKAnika Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−6,973 sh	$25.42	−$177K	122,641
2024-03-11	ANIKAnika Therapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	40,003
2024-03-11	ANIKAnika Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	—	—	142,642
2024-03-11	ANIKAnika Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−6,473 sh	$25.42	−$165K	136,169
2024-03-11	ANIKAnika Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+30.1K sh	—	—	166,228

Recent filings

Accepted (ET)
Apr 164
Blanchard Cheryl R0001193125-26-159316
SEC(opens sec.gov)
Mar 174
Blanchard Cheryl R0001193125-26-111494
SEC(opens sec.gov)
Mar 114
Blanchard Cheryl R0001193125-26-102239
SEC(opens sec.gov)
Aug 54
Blanchard Cheryl R0000950170-25-102476
SEC(opens sec.gov)

Companies

Address

828 WINTER STREET SUITE 300

WALTHAM, MA, 02451